Integrating Locoregional Therapies Into Oncology Value Frameworks to Improve Patient-Centered Decision-Making and Outcomes

Affiliations

¹ ClearView Healthcare Partners, Boston, Massachusetts.
² Department of Radiation Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.
³ Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
⁴ Radiation Oncology Institute, Samson Assuta Ashdod University Hospital, Ben-Gurion University of the Negev, Ashdod, Israel.
⁵ Department of Radiation Oncology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire.
⁶ Cancer Outcomes Public Policy, and Effectiveness Research Center at Yale, New Haven, Connecticut.
⁷ Department of Radiation Oncology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire; Cancer Outcomes Public Policy, and Effectiveness Research Center at Yale, New Haven, Connecticut. Electronic address: James.b.yu@hitchcock.org.

Kwabena B Asare et al. Pract Radiat Oncol. 2026.

. 2026 Feb 28:S1879-8500(26)00062-7.

doi: 10.1016/j.prro.2026.02.009. Online ahead of print.

¹ ClearView Healthcare Partners, Boston, Massachusetts.
² Department of Radiation Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.
³ Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
⁴ Radiation Oncology Institute, Samson Assuta Ashdod University Hospital, Ben-Gurion University of the Negev, Ashdod, Israel.
⁵ Department of Radiation Oncology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire.
⁶ Cancer Outcomes Public Policy, and Effectiveness Research Center at Yale, New Haven, Connecticut.
⁷ Department of Radiation Oncology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire; Cancer Outcomes Public Policy, and Effectiveness Research Center at Yale, New Haven, Connecticut. Electronic address: James.b.yu@hitchcock.org.

No abstract available

LinkOut - more resources